Clinical Trials Browser

Observational × Biliary Tract Neoplasms × Capecitabine × Clear all

NCT06975917 2025-05-16

TOG-SAFRADJU

Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms

NCT04856761 2022-08-18

A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence, Cholangiocarcinoma